Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yunshu Su, Xiaoli Wang, Jun Li, Junming Xu & Lijun Xu. (2015) The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review. Drug Design, Development and Therapy 9, pages 5439-5445.
Read now
Read now
Articles from other publishers (15)
Daniah Alsufyani & James Lindesay. (2023) Evidence of cancer-linked rodent zoonoses from biophysical genomic variations. Scientific Reports 13:1.
Crossref
Crossref
Jordan Da Silva, Amina Jouida, Julien Ancel, Véronique Dalstein, Julie Routhier, Gonzague Delepine, Jérôme Cutrona, Antoine Jonquet, Maxime Dewolf, Philippe Birembaut, Gaëtan Deslée, Myriam Polette & Béatrice Nawrocki‐Raby. (2020)
FHIT
low
/
pHER2
high
signature in non‐small cell lung cancer is predictive of
anti‐HER2
molecule efficacy
. The Journal of Pathology 251:2, pages 187-199.
Crossref
Crossref
Kathrin H. Götz, Martin Mex, Katrin Stuber, Fabian Offensperger, Martin Scheffner & Andreas Marx. (2019) Formation of the Alarmones Diadenosine Triphosphate and Tetraphosphate by Ubiquitin- and Ubiquitin-like-Activating Enzymes. Cell Chemical Biology 26:11, pages 1535-1543.e5.
Crossref
Crossref
Francesca Bianchi, Marianna Sasso, Federica Turdo, Giovanni L. Beretta, Patrizia Casalini, Cristina Ghirelli, Lucia Sfondrini, Sylvie Ménard, Elda Tagliabue & Manuela Campiglio. (2015) Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells. Journal of Cellular Physiology 230:11, pages 2661-2670.
Crossref
Crossref
Amy L Masson, Bente A Talseth-Palmer, Tiffany-Jane Evans, Desma M Grice, Garry N Hannan & Rodney J Scott. (2014) Expanding the genetic basis of copy number variation in familial breast cancer. Hereditary Cancer in Clinical Practice 12:1.
Crossref
Crossref
Charles Brenner. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
Eugenio Gaudio, Francesco Paduano, Riccardo Spizzo, Apollinaire Ngankeu, Nicola Zanesi, Marco Gaspari, Francesco Ortuso, Francesca Lovat, Jonathan Rock, Grace A. Hill, Mohamed Kaou, Giovanni Cuda, Rami I. Aqeilan, Stefano Alcaro, Carlo M. Croce & Francesco Trapasso. (2013) Fhit Delocalizes Annexin A4 from Plasma Membrane to Cytosol and Sensitizes Lung Cancer Cells to Paclitaxel. PLoS ONE 8:11, pages e78610.
Crossref
Crossref
Barbara Seliger & Rolf Kiessling. (2013) The two sides of HER2/neu: immune escape versus surveillance. Trends in Molecular Medicine 19:11, pages 677-684.
Crossref
Crossref
Young Jeong. (2013) Promoter methylation status of the FHIT gene and Fhit expression: Association with HER2/neustatus in breast cancer patients. Oncology Reports.
Crossref
Crossref
Irene Romero, Marisol Martinez, Cristina Garrido, Antonia Collado, Ignacio Algarra, Federico Garrido & Angel M Garcia‐Lora. (2012)
The tumour suppressor
Fhit
positively regulates MHC class I expression on cancer cells
. The Journal of Pathology 227:3, pages 367-379.
Crossref
Crossref
CT Zhang, R Lu, YL Lin, RL Liu, ZH Zhang, K Yang, RF Dang, HT Zhang, YG Shen, PZ Kong, HL Ren, XL Li, W Quan & Y Xu. (2012) The Significance of Fragile Histidine Triad Protein as a Molecular Prognostic Marker of Bladder Urothelial Carcinoma. Journal of International Medical Research 40:2, pages 507-516.
Crossref
Crossref
Alessandra Drusco, Yuri Pekarsky, Stefan Costinean, Anna Antenucci, Laura Conti, Stefano Volinia, Rami I. Aqeilan, Kay Huebner & Nicola Zanesi. (2011) Common Fragile Site Tumor Suppressor Genes and Corresponding Mouse Models of Cancer. Journal of Biomedicine and Biotechnology 2011, pages 1-10.
Crossref
Crossref
Md. Imtaiyaz Hassan, Abdullah Naiyer & Faizan Ahmad. (2009) Fragile histidine triad protein: structure, function, and its association with tumorogenesis. Journal of Cancer Research and Clinical Oncology 136:3, pages 333-350.
Crossref
Crossref
Prisco Mirandola, Giuliana Gobbi, Ivonne Sponzilli, Chiara Malinverno, Andrea Cavazzoni, Roberta Alfieri, Pier Giorgio Petronini & Marco Vitale. (2009) TRAIL‐induced apoptosis of FHIT‐negative lung cancer cells is inhibited by FHIT re‐expression. Journal of Cellular Physiology 220:2, pages 492-498.
Crossref
Crossref
Charles Brenner. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.